Table 2.
Adverse events.
| Tumor type | Dose cohort | Adverse event | Grade | Intervention | Resolved |
|---|---|---|---|---|---|
| BC | 0.3 mg per kg | Headache | I | No | Yes |
| BC | 0.3 mg per kg | Pain left cheek | I | No | Yes |
| BC | 0.3 mg per kg | Flush | I | No | Yes |
| BC | 0.3 mg per kg | Dizziness | I | No | Yes |
Adverse events that occurred during the course of the study which were possibly related to imaging agent administration and scored according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.03: June 14, 2010.
BC breast cancer.